Medicare Enrolled
Dr. Moussa Faminini, MD
Endocrinology · Encino, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Faminini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faminini?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Faminini
Dr. Moussa Faminini is an endocrinology specialist in Encino, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Faminini performed 5,177 Medicare services across 3,419 unique beneficiaries.
Between the years covered by Open Payments, Dr. Faminini received a total of $16,081 from 59 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Faminini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$16,081 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,177
Medicare services
Top 15% in CA for endocrinology
3,419
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~272 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,185 | $77 | $148 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
878 | $77 | $125 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
867 | $48 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
561 | $107 | $194 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
424 | $140 | $200 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
159 | $102 | $269 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
157 | $36 | $60 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
124 | $174 | $375 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $12 | $66 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
99 | $178 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
96 | $136 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
96 | $153 | $230 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
76 | $44 | $80 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
71 | $99 | $269 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
61 | $13 | $80 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
60 | $81 | $152 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
55 | $107 | $203 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $50 | $86 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
19 | $10 | $153 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
18 | $59 | $75 |
| Ultrasound of abdominal aorta An imaging test that uses sound waves to create pictures of the abdominal aorta, the large blood vessel that carries blood from the heart to the lower body. |
15 | $123 | $250 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
13 | $174 | $385 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
12 | $222 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,081
Total received (2018-2024)
Avg $2,297/year across 7 years
Top 14% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,847 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$234 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,501
2023
$3,004
2022
$3,015
2021
$2,559
2020
$1,223
2019
$1,940
2018
$1,839
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$526
AstraZeneca Pharmaceuticals LP
$499
ABBVIE INC.
$306
Novo Nordisk Inc
$160
Phathom Pharmaceuticals, Inc.
$135
Novartis Pharmaceuticals Corporation
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
Abbott Laboratories
$108
Lilly USA, LLC
$90
AIMMUNE THERAPEUTICS, INC.
$80
IRONWOOD PHARMACEUTICALS, INC
$63
Radius Health, Inc.
$60
GlaxoSmithKline, LLC.
$51
SANOFI-AVENTIS U.S. LLC
$42
Ascendis Pharma Inc
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
Sumitomo Pharma America, Inc.
$27
Kowa Pharmaceuticals America, Inc.
$22
IBSA Pharma Inc.
$21
Dexcom, Inc.
$18
Top 3 companies account for 53.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,827
Amgen Inc.
$1,683
Janssen Pharmaceuticals, Inc
$1,679
Novo Nordisk Inc
$1,286
ABBVIE INC.
$1,019
Amarin Pharma Inc.
$936
GlaxoSmithKline, LLC.
$817
Biohaven Pharmaceuticals, Inc.
$482
Abbott Laboratories
$436
AbbVie Inc.
$404
PFIZER INC.
$351
Astellas Pharma US Inc
$320
Nestle HealthCare Nutrition Inc.
$320
Lilly USA, LLC
$302
Boehringer Ingelheim Pharmaceuticals, Inc.
$287
AbbVie, Inc.
$249
Merck Sharp & Dohme Corporation
$243
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$241
Takeda Pharmaceuticals U.S.A., Inc.
$237
Nevro Corp.
$217
Bayer Healthcare Pharmaceuticals Inc.
$217
Novartis Pharmaceuticals Corporation
$207
Allergan Inc.
$149
Ironwood Pharmaceuticals, Inc
$146
IBSA Pharma Inc.
$143
Phathom Pharmaceuticals, Inc.
$135
Corcept Therapeutics
$125
Otsuka America Pharmaceutical, Inc.
$124
Xeris Pharmaceuticals, Inc.
$122
Alexion Pharmaceuticals, Inc.
$105
Radius Health, Inc.
$104
Bayer HealthCare Pharmaceuticals Inc.
$97
GENZYME CORPORATION
$90
IRONWOOD PHARMACEUTICALS, INC
$88
SANOFI-AVENTIS U.S. LLC
$83
AIMMUNE THERAPEUTICS, INC.
$80
NESTLE HEALTHCARE NUTRITION INC.
$71
Horizon Therapeutics plc
$65
Edwards Lifesciences Corporation
$65
Biohaven Pharmaceutical Holding Company Ltd.
$54
Eisai Inc.
$45
Sunovion Pharmaceuticals Inc.
$44
Endo Pharmaceuticals Inc.
$31
Ascendis Pharma Inc
$28
Sumitomo Pharma America, Inc.
$28
Teva Pharmaceuticals USA, Inc.
$27
Esperion Therapeutics, Inc.
$25
Shire North American Group Inc
$25
IDORSIA PHARMACEUTICALS US INC
$23
Aegerion Pharmaceuticals, Inc.
$22
Kowa Pharmaceuticals America, Inc.
$22
Shield Therapeutics Inc
$22
Nabriva Therapeutics, plc
$22
ARBOR PHARMACEUTICALS, INC.
$20
Impax Laboratories, Inc.
$20
Egalet US Inc
$20
MannKind Corporation
$18
Dexcom, Inc.
$18
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 32.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · AREXVY · AVSOLA · Aimovig · BAQSIMI · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Creon · Dayvigo · Dexcom G6 Transmitter · EVENITY · Edarbyclor · FARXIGA · FREESTYLE LIBRE 3 · GEMTESA · GVOKE HYPOPEN · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Linzess · MOUNJARO · MYALEPT · MYRBETRIQ · Myrbetriq · NASCOBAL · NEXLETOL · NURTEC ODT · Omnia · Ozempic · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · RAYOS · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SOLIQUA 100/33 · SPRIX · STEGLATRO · SYMBICORT · SYNTHROID · Synthroid · TEPEZZA · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Tirosint · Trintellix · UBRELVY · VIBERZI · VOQUEZNA · Vascepa · XARELTO · XIFAXAN · XIFAXANIBSD · Xenleta · ZENPEP · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
225
Per 100K population
2.3
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Faminini is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Faminini experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Faminini performed 1,185 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faminini receive payments from pharmaceutical companies?
Yes. Dr. Faminini received a total of $16,081 from 59 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faminini's costs compare to other endocrinologists in Encino?
Dr. Faminini's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faminini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Encino
Browse endocrinologists in Encino ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology